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The purpose of this research is to enhance an HMM-based named entity recognizer in the biomedical domain. First, we analyze
the characteristics of biomedical named entities. Then, we propose a rich set of features, including orthographic, morphological,
part-of-speech, and semantic trigger features. All these features are integrated via a Hidden Markov Model with back-oﬀ modeling.
Furthermore, we propose a method for biomedical abbreviation recognition and two methods for cascaded named entity recogni-
tion. Evaluation on the GENIA V3.02 and V1.1 shows that our system achieves 66.5 and 62.5 F-measure, respectively, and outper-
forms the previous best published system by 8.1 F-measure on the same experimental setting. The major contribution of this paper
lies in its rich feature set specially designed for biomedical domain and the eﬀective methods for abbreviation and cascaded named
entity recognition. To our best knowledge, our system is the ﬁrst one that copes with the cascaded phenomena.
 2004 Elsevier Inc. All rights reserved.
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Named entity recognition (NER) automatically
identiﬁes names in texts and classiﬁes them into prede-
ﬁned classes. The NER task is deﬁned by the message
understanding conferences (MUC), where the names
of entities in the newswire domain, such as PERSON,
ORGANIZATION, LOCATION, and etc., are recog-
nized. With the exploding amount of biomedical litera-
tures, NER is strongly demanded in the biomedical
domain. It is a useful technique for many applications,1532-0464/$ - see front matter  2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.jbi.2004.08.005
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Linguistics Department, 66041 Saarbru¨cken, Germany.such as text mining in the biomedical domain, bioinfor-
matics tools, biomedical database building, etc. In the
biomedical domain, not only the names of entities, such
as protein, gene, and virus, but also the names of some
concepts, such as names of biomedical processes, need
to be recognized.
In previous research work, many NER systems have
been applied successfully in the newswire domain [1–3].
Recently, more and more explorations have been done
to port existing NER systems into the biomedical do-
main [4–10,12]. Since most of the systems are evaluated
on diﬀerent training data, we can hardly make compar-
ison. However, there is still some room for improvement
based on the reported results of these systems.
In this paper, we will study how to adapt a general
Hidden Markov Model (HMM)-based named entity
recognizer [1] to the biomedical domain. We specially
explore various features for biomedical named entities
and propose methods to cope with abbreviations and
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features (orthographic, morphological, part-of-speech,
and head noun trigger features) and methods (an
abbreviation recognition algorithm and two cascaded
named entity recognition methods) are integrated in
our system. The experiment shows that our system sig-
niﬁcantly outperforms the previous best published
system.
The rest of the paper is organized as follows. Section
2 summarizes special characteristics of biomedical
named entities. In Section 3, we provide detailed
description of our HMM-based named entity recogni-
tion model and present various methods for abbrevia-
tion recognition and cascaded named entity
recognition. In Section 4, the rich feature set is de-
scribed in detail. In Section 5, we show our experimen-
tal conﬁgurations and various experimental results.
Section 6 presents the related work. Finally, in Chapter
7 we conclude this paper with future work.Table 1
Orthographic features
Fo Name Example
Comma ,
Dot .
LeftRoundBracket (
RightRoundBracket )
LeftSquareBracket [
RightSquareBracket ]
RomanDigit II
GreekLetter Beta
StopWord in, at
ATCGsequence AACAAAG
OneDigit 5
AllDigits 60
DigitCommaDigit 1,25
DigitDotDigit 0.5
OneCap T
AllCaps CSF
CapLowAlpha All
CapMixAlpha IgM
LowMixAlpha kDa
AlphaDigitAlpha H2A
AlphaDigit T4
DigitAlphaDigit 6C2
DigitAlpha 19D2. Characteristics of biomedical named entities
Since named entity recognition in the newswire do-
main is successful and mature, people may ask what
else can be done in the biomedical domain and what
diﬀerence exists between the two domains. To answer
these questions, we study the special characteristics of
various biomedical named entities to get a clear under-
standing before bringing out our solutions. In sum-
mary, biomedical named entities have following
special characteristics:
1. Biomedical named entities often have pre-modiﬁers,
e.g., activated B cell lines, and are sometimes very
long, e.g., 47 kDa sterol regulatory element binding
factor. These are the main causes of diﬃculty of iden-
tifying the boundary of a named entity.
2. Two or more biomedical named entities can share one
head noun by using the conjunction or disjunction
construction, e.g., 91 and 84 kDa proteins. It is hard
to resolve such phenomenon.
3. One biomedical named entity may have various
forms, e.g., N-acetylcysteine, N-acetyl-cysteine, NAce-
tyl Cysteine, etc. Especially, the capitalization infor-
mation may not be so useful in this domain, since
the use of capitalization is casual.
4. Biomedical named entities may be cascaded. One
named entity may be embedded in another named
entity, e.g., <PROTEIN><DNA>kappa 3</DNA>
binding factor </PROTEIN>. More eﬀorts have to
be made to identify such named entities.
5. Abbreviations are frequently used in the biomedical
domain, e.g., TCEd, IFN, TPA, etc. Since abbrevia-
tions carry less information than their full forms, it
is more diﬃcult to classify them.These above factors make NER in the biomedical do-
main diﬃcult. Therefore, it is necessary to explore rich
features and eﬀective methods to deal with the special
characteristics in the biomedical domain.3. Feature set
3.1. Orthographic features (Fo)
Orthographic features are designed to capture word
formation information, such as capital letters, numeric
characters, and their combinations. Orthographic infor-
mation have been widely used in NER, such as [1,4–
6,8,9]. Generally, orthographic features are manually
designed and aim to group words by similar formations.
In the biomedical domain, orthographic features are
likely to be served as indicators of unknown words, such
as unknown abbreviations. For example, suppose IL-2
is in the training data, but IL-12 is not. Fortunately,
we can guess that IL-12 is similar to IL-2 based on their
orthographic features. In our work, we manually design
orthographic features based on the characteristics of
biomedical names. Table 1 shows the list of ortho-
graphic features by the descending order of priority.
From Table 1, we can ﬁnd that the features, such as
GreekLetter, RomanDigit, ATCGsequence, are specially
designed for the biomedical domain. The features
dealing with mixed alphabets and digits, such as Alpha-
DigitAlpha, CapMixAlpha, etc., are beneﬁcial for bio-
medical abbreviations. Moreover, the features, such as
ATCGsequence, identify the similarity of the words
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GA, etc. Besides these, some features, such as comma, dot,
StopWord, etc., are to provide information to detect the
boundaries of named entities. Especially, parentheses,
such as LeftRoundBracket, RightRoundBracket, Left-
SquareBracket, and RightSquareBracket, are often used
to indicate the deﬁnitions of biomedical abbreviations.
In Section 4.2, we will explain how to make use of
parentheses to deal with abbreviations in detail.
3.2. Morphological feature (Fm)
Morphological information, such as preﬁx and suﬃx,
is considered as an important cue for terminology iden-
tiﬁcation. In our system, we use a statistical method to
get the most frequent 100 preﬁxes and suﬃxes from
the training data as candidates. Then, each of these can-
didates is evaluated according to the Eq. (1).
Wti ¼ #IN i #OUT ið ÞNi ð1Þ
in which, #INi is the number that the preﬁx/suﬃx i oc-
curs within NEs; #OUTi is the number that the preﬁx/
suﬃx i occurs out of named entities; Ni is the total num-
ber of the preﬁx/suﬃx i.
Equation (1) assumes that the particular preﬁx/suﬃx,
which is most likely inside and least likely outside named
entities, may be thought useful. The candidates with Wt
above a certain threshold (0.7 in our experimentation)
are selected. Then, we calculate the frequency of each
preﬁx/suﬃx in each entity class and group the preﬁxes/
suﬃxes with the similar distribution among entity clas-
ses into one feature. This is because preﬁxes/suﬃxes with
the similar distributions have similar contributions, and
it avoids suﬀering from data sparseness problem. Some
of morphological features are listed in Table 2.
From Table 2, the suﬃxes cin, mide, and zole are
grouped into one feature sOOC because they all haveTable 2
Examples of morphological features
Fm Name Preﬁx/Suﬃx Example
sOOC cin Actinomycin
mide Cycloheximide
zole Sulphamethoxazole
sLPD lipid Phospholipids
rogen Estrogen
vitamin Dihydroxyvitamin
sCTP blast Erythroblast
cyte Thymocyte
phil Eosinophil
sPEPT peptide Neuropeptide
sMA ma Hybridoma
sVIR virus Cytomegalovirushigh frequencies in the entity class OTHER-ORGAN-
IC-COMPOUND and relatively low frequencies in the
other entity classes. In our work, totally 37 preﬁxes
and suﬃxes were selected and grouped to 23 features.
3.3. Part-of-speech features (Fpos)
In the previous NER in the newswire domain, part-
of-speech (POS) features are proven useless, as POS fea-
tures may aﬀect the use of some important capitalization
information [1]. However, the capitalization informa-
tion in the biomedical domain is not as useful as it in
the newswire domain. Moreover, since many biomedical
named entities are descriptive and long, identifying en-
tity boundary is not a trivial task. As a syntactical fea-
ture, POS tagging can help to capture the noun phrase
region. Therefore, it is useful for biomedical NER,
based on the assumption that a named entity is more
likely to be a noun phrase.
In our work, we adapt a HMM-based POS tagger to
the biomedical domain by using GENIA corpus as the
training data. The POS tagger achieves the precision of
97.37 using 80% of GENIA V2.1 corpus (536 abstracts,
123K words) as training data and the rest 20% (134 ab-
stracts, 29K words) as test data. In our NER system,
each word is assigned a POS feature by this POS tagger.
3.4. Semantic trigger features
We design semantic trigger features to indicate certain
entity classes based on the semantic information. Trigger
words are key words inside or outside of named entities.
Initially, we collected two types of semantic triggers:
head noun triggers and special verb triggers.
3.5. Head noun triggers (Fhnt)
The head noun is the main noun or noun phrase of
some compound words and describes the function or the
property, e.g.,Bcells is the headnoun for the named entity
activated humanBcells.Comparedwith theotherwords in
named entities, the head noun is amuchmore decisive fac-
tor for distinguishing entity classes. For instance,
<OTHER-NAME>IFN-gamma treatment</OTHER-
NAME>
<DNA>IFN-gamma activation sequence</DNA>
Both of the instances above begin with the IFN-gam-
ma with only a diﬀerence in head nouns, treatment and
sequence. These two biomedical named entities belong
to two diﬀerent classes: OTHER-NAME and DNA. This
example implies that no matter how many similar
expressions are within entities, entity classes are nor-
mally determined by head nouns. The usefulness of the
head noun is also supported by [11].
Table 3
Examples of head noun triggers
Class 1-gram 2-grams
PROTEIN Kinase Binding protein
Interleukin Activator protein
Interferon Cell receptor
Ligand Gene product
VIRUS Virus Recombinant virus
Provirus Lymphotropic herpesvirus
Cytomegalovirus Virus particles
Adenovirus Immunodeﬁciency virus
DNA DNA X chromosome
Breakpoint a-Promoter
cDNA Binding motif
Chromosome Promoter element
Table 4
Special verb triggers
Activate Associate Bind Block Clone
Demonstrate Express Identify Increase Induce
Inhibit Investigate Involve Isolate Mediate
Observe Reduce Regulate Reveal Stimulate
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nouns automatically from the training data, and rank
them by their frequencies. According to the experiment,
we select 60%of top ranked head nouns as trigger features
for each entity class. Some examples are shown in Table 3.
In the future application, we may also extract head
nouns from public resources.
3.6. Special verb triggers (Fsvt)
Besides collecting trigger words inside named entities,
such as head noun triggers, we can also use trigger words
from the local context of named entities. Recently, some
frequent verbs in MEDLINE have been proven useful
for extracting interactions between biomedical entities,
e.g., the protein–protein interactions [14,15]. Therefore,
we have intuition that particular verbs may also be useful
for biomedical NER. For instance, the verb bind often
indicates the interaction between proteins.
In our work, we selected 20 most frequent verbs
which occur adjacent to named entities from the training
data automatically as the verb trigger features, which
are shown in Table 4.4. Methods
4.1. HMM-based named entity recognizer
Hidden Markov Model (HMM) is a statistical meth-
od. In the past 15 years, HMM has been successfully
used in a wide range of applications, such as speech rec-
ognition and natural language processing. In HMM, asequence of output symbols is generated in addition to
a Markov state sequence. It is a latent variable model
in the sense that only the output sequence is observed
while the state sequence remains ‘‘hidden.’’
In named entity recognition, the input word se-
quence, e.g., sentence, can be regarded as the observed
sequence and the output tag sequence is the statistically
optimal state sequence corresponding to the observed
word sequence.
In our work, the name entity recognizer is adapted
from the previous work, the HMM-based Named Entity
Recognizer on MUC [1]. The core technique is a Hidden
Markov Model described as follows:
The named entity recognizer tries to ﬁnd the most
likely tag sequence T n1 ¼ t1t2    tn for a given sequence
of tokens On1 ¼ o1o2    on that maximizes PðT n1jOn1Þ. In
the token sequence On1, the token oi is deﬁned as oi =
Æfi, wiæ, where wi is the ith word and fi is the feature set as-
signed to the wordwi. The feature set is introduced in Sec-
tion 3. In the tag sequence T n1, each tag ti is structural and
consists of three parts: the boundary category, the entity
class and the feature set. The boundary category indicates
whether the word itself is a named entity, or the word is at
the beginning, in the middle, or at the end of a named en-
tity. The entity class consists of aNOT-NAMEclass and a
predeﬁned set of entity classes. The feature set is added in
order to representmore accuratemodels based on the lim-
ited number of boundary categories and entity classes.
In the model, P ðT n1jOn1Þ an be represented as
log PðT n1jOn1Þ ¼ log P ðT n1Þ þ log
P ðT n1;On1Þ
P ðT n1Þ  P ðOn1Þ
: ð2Þ
The second term of the right-hand side of Eq. (2) is the
mutual information between T n1 and O
n
1. We assume mu-
tual information independence:
log
P ðT n1;On1Þ
PðT n1Þ  P ðOn1Þ
¼
Xn
i¼1
log
P ðti;On1Þ
P ðtiÞ  P ðOn1Þ
: ð3Þ
Applying Eq. (3) to (2), we have:
log PðT n1jOn1Þ ¼ log P ðT n1Þ 
Xn
i¼1
log P ðtiÞ
þ
Xn
i¼1
log P ðtijOn1Þ ð4Þ
The ﬁrst term in the Eq. (4) can be computed by
applying chain rules. Each tag is assumed to be probabi-
listically dependent on the N  1 previous tags in the
N-gram modeling. The second term is the sum of log
probabilities of all the tag instances. Ideally, the third
term can be estimated by the forward–backward algo-
rithm recursively [16]. For eﬃciency, an alternative
back-oﬀ modeling approach by means of constraint
relaxation was applied in our model. This approach
enables the decoding process eﬀectively ﬁnd a near opti-
mal frequently occurred pattern entry in determining the
Fig. 1. Algorithm for abbreviation recognition.
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of the back-oﬀ modeling can be found in [1].
The Viterbi algorithm [17] is implemented to ﬁnd the
most likely tag sequence in the state space of the possible
tag distribution based on the state transition probabili-
ties. Meanwhile, some constraints on the boundary cat-
egory and entity category between two consecutive tags
are applied to ﬁlter the invalid name tags.
4.2. Method for abbreviation recognition
Abbreviations are widely used in the biomedical do-
main. Therefore, it is important to resolve this problem
in the biomedical domain.
In our current system, we incorporate a method to
classify an abbreviation by mapping the abbreviation
to its full form. This approach is based on the assump-
tion that it is easier to classify the full form than its
abbreviation. In most cases, this assumption is valid
because the full form has more information than its
abbreviation to capture its entity class. Moreover, if
we can map the abbreviation to its full form, the recog-
nized abbreviation is also helpful for classifying the
same forthcoming abbreviations within the current
document.
In practice, the abbreviation and its full form often
occur simultaneously with parenthesis when an abbrevi-
ation ﬁrst appears in biomedical documents [18,20].
There are often two cases:
1. full form (abbreviation)
2. abbreviation (full form)
Most patterns conform to the ﬁrst case and if the con-
tent inside the parenthesis consists of more than two
words, the second case is assumed [18].
In these two cases, the use of parenthesis is both evi-
dential and confusing. On one hand, it is evidential be-
cause it indicates the mapping of an abbreviation to its
full form. On the other hand, it is confusing because it
makes the annotation more complicated and inconsis-
tent. Sometimes, an abbreviation and its full form are
annotated separately, as
<CELL-TYPE>human mononuclear leukocytes</CELL-
TYPE> (<CELL-TYPE>hMNL</CELL-TYPE>),
and sometimes, they are all embedded in a whole entity,
such as
<OTHER-NAME>leukotriene B4 (LTB4) generation</
OTHER-NAME>.
Therefore, parenthesis needs to be treated specially.
In this paper, we develop an abbreviation recognition
algorithm described in Fig. 1.The main idea of the algorithm in Fig. 1 is described
as follows. In the preprocessing stage, we remove the
abbreviation and parentheses from the sentence, where
an abbreviation is ﬁrst deﬁned. This measure will make
the annotation simpler and the recognizer more eﬀec-
tive. Then, we determine which case the abbreviation
deﬁnition belongs to and record the original positions
of the abbreviation and parentheses. After applying
our named entity recognizer to the sentence, we restore
the abbreviation and parentheses to the recorded posi-
tions. Next, the abbreviation is classiﬁed based on the
two priorities (from high to low): the class of its full
form and the class of the abbreviation itself identiﬁed
by the recognizer. Finally, the same abbreviations in
the rest sentences of the current document are assigned
the same entity class.
4.3. Methods for cascaded named entity recognition
As mentioned in Section 2, cascaded-annotation is a
special problem in biomedical NER. For instance,
‘‘<CELL-LINE><VIRUS>HTLV-I</VIRUS>-infect-
ed cord blood lymphocytes </CELL-LINE>’’ belongs to
the class CELL-LINE and embeds a virus name HTLV-
I. In cascaded named entity recognition, we shall recog-
nize both the embedded and the longest named entities.
However, people currently care more about the longest
named entities for two reasons. First, the longest named
entities are more likely to be the subjects that people
want to study. Second, they keep all information about
the embedded named entities. Therefore, whether tag-
ging the embedded named entities or not depends on
user requirements under diﬀerent circumstances. In our
work, we propose two approaches: a post-processing
Table 6
Examples of post-processing rules for cascaded named entity
recognition
Rule instance <DNA> = <PROTEIN> binding site
From pattern <NAME> = <NAME> [head nouns]
Example A Myc-associated zinc ﬁnger protein binding
site is one of . . .
Rule instance <PROTEIN> = <VIRUS> <PROTEIN>
From pattern <NAME> = <NAME1> <NAME2>
Example Nevertheless, the simian EBV LMP1s retain
most functions in . . .
Rule instance <CELL-TYPE> = human <CELL-TYPE>
From pattern <NAME> = [modiﬁer] <NAME>
Example . . .suggests that human NK cells provide
an eﬀective . . .
Rule instance <CELL-TYPE> = <VIRUS>-infected
<CELL-TYPE>
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HMM-based cascaded recognition approach.
4.4. Post-processing rule-based cascaded recognition
approach
The post-processing rule-based approach aims to rec-
ognize the longest named entities. In thepreviousnon-cas-
caded recognition, the named entity recognizermay fail to
recognize someof the longestnamedentities, since it some-
times recognizes embedded named entities. For example:
In the above case, the previous system recognizes the
From pattern <NAME> = <NAME1> [words] <NAME2>
Example . . . p24 production by HIV-infected human
macrophages when . . .embedded TISSUE ‘‘bone marrow,’’ while we prefer to
recognize the entity CELL-LINE. The cause of errors
of this type is that a substring embedded in a named en-
tity itself is another named entity and is recognized as
such to prevent the whole string from being correctly
recognized. In the above example, the word ‘‘marrow’’
is a head noun for TISSUE, thus ‘‘bone marrow’’ is
likely to be recognized as the entity TISSUE. Although
‘‘cell line’’ is a head noun for CELL-LINE, the context is
too long to capture.
We propose a post-processing rule-based approach to
deal with these cases. The main idea is that we develop a
set of patterns which help recognize the longest named
entities based on the embedded ones. From GENIA cor-
pus annotation, we collect four basic patterns of cas-
caded named entities. In addition, we also extend the
patterns by combining the basic ones iteratively as
shown in Table 5.
Based on these patterns, we can construct a rule set
automatically from the training corpus. Table 6 shows
some post-processing rules.
After named entity recognition by our recognizer, we
get an initial result. Then, we develop a post-processing
procedure by applying the rules above to the initial result.
For example, given the initial result ‘‘a <PRO-
TEIN>Myc-associated zinc ﬁnger protein</PROTEIN>Table 5
Patterns of cascaded named entities
Basic patterns
<NAME> = <NAME> [head nouns]
<NAME> = [modiﬁer] <NAME>
<NAME> = <NAME1> <NAME2>
<NAME> = <NAME1> [words] <NAME2>
Extended patterns
<NAME> = [modiﬁer] <NAME> [head nouns]
<NAME> = [modiﬁer] <NAME1> <NAME2>
<NAME> = <NAME1> <NAME2> [head nouns]
. . .binding site is one of . . .,’’ the post-processing procedure
ﬁnds that it matches the rule ‘‘<DNA> = <PROTEIN>
binding site.’’ After post-processing, the ﬁnal result turns
to ‘‘a <DNA> Myc-associated zinc ﬁnger protein binding
site </DNA> is one of . . .’’ In addition, the post-process-
ing rules are applied iteratively until no new match can
be found. For example, given the initial result ‘‘. . .<AMI-
NO-ACID-MONOMER>tyrosine </AMINO-ACID-
MONOMER>kinase inhibitor . . .,’’ the post-processing
procedure ﬁnds that it matches the rule ‘‘<PRO-
TEIN> = <AMINO-ACID-MONOMER> kinase’’ and
changes it to ‘‘. . .<PROTEIN> tyrosine kinase </PRO-
TEIN> inhibitor . . .’’ in the ﬁrst iteration. In the next iter-
ation, the post-processing procedure ﬁnds that the
intermediate result matches the rule ‘‘<OTHER-OR-
GANIC-COMPOUND> = <PROTEIN> inhibitor’’ and
updates it again. Since no more matches will occur in
the following iterations, the ﬁnal result is ‘‘. . .<OTHER-
ORGANIC-COMPOUND> tyrosine kinase inhibitor </
OTHER-ORGANIC-COMPOUND> . . .’’ In this way,
we are able to recognize the longest named entity.4.5. HMM-based cascaded recognition approach
Besides the post-processing rule-based approach, we
also propose an HMM-based cascaded recognition ap-
proach to recognize named entities with cascaded-anno-
tation. The HMM-based cascaded recognition approach
starts from the shortest embedded named entity and ex-
tends to the longer named entity iteratively.
We train two HMM models in this approach. The
ﬁrst model is our named entity recognizer, which is
mainly to recognize short embedded named entities. Be-
sides this, we also train another HMM model to itera-
tively extend the short entities. To train this iterative
J. Zhang et al. / Journal of Biomedical Informatics 37 (2004) 411–422 417model, we use the cascaded-annotations of the GENIA
corpus and transform them into a new training data set.
For example:Fig. 3. Algorithm of a generalized recursive method for all-level
cascaded named entity recognition.We substitute a class-representing token ‘‘[PRO-
TEIN]’’ for the embedded name of protein. After this
transformation, all cascaded-annotated entities in the
training data become non-cascaded. We train a HMM
model on this training data as a cascaded recognition
model. Intuitively, the HMM model captures local
context information more easily than long context
information. Some long cascaded named entities may
be diﬃcult to be recognized in one pass as shown in
the previous section. We hope that they can be recog-
nized by two or more iterations if they are missed in
the ﬁrst pass. Therefore, we can use the same HMM
method iteratively and do not need any post-processing
step. One limitation of this approach may be that the
following iterations rely on the ﬁrst recognition pass.
In an ideal situation, if the performance is high in the
ﬁrst pass, the longer named entities are likely to be rec-
ognized. In our work, we just concern about the perfor-
mance of the longest named entities, so that the
evaluation is conducted on them. The algorithm of the
HMM-based cascaded recognition approach is shown
in Fig. 2.
In addition, we also generalize the model to a recur-
sive process which recognizes all levels of the cascaded
named entities, i.e., not only the longest named entities
but also the embedded ones. The algorithm for this gen-
eralized method is shown in Fig. 3.Fig. 2. Algorithm for the HMM-based cascaded recognition
approach.5. Experiments
5.1. GENIA corpus
Currently, the GENIA corpus2 is the largest anno-
tated text resource in the biomedical domain available
to public [19]. The annotation of the biomedical
named entities is based on the GENIA ontology. In
our task, we recognize 22 distinct entity classes3 deﬁned
in the GENIA ontology, including MULTI-CELL,
MONO-CELL, VIRUS, BODY-PART, TISSUE,
CELL-TYPE, CELL-COMPONENT, CELL-LINE,
OTHER-ARTIFICIAL-SOURCE, PROTEIN, PEP-
TIDE, AMINO-ACID-MONOMER, DNA, RNA,
POLYNUCLEOTIDE, NUCLEOTIDE, LIPID, CAR-
BOHYDRATE, OTHER-ORGANIC-COMPOUND,
INORGANIC, ATOM, andOTHER. In our experiment,
three versions are used, which are V1.1, V2.1, and V3.02.
GENIA Version 1.1 (V1.1)—It consists of 670 MED-
LINE abstracts. Since a lot of previous related works
are based on this version, we use it to compare our result
with the others.
GENIA Version 2.1 (V2.1)—It consists of the same
670 abstracts as V1.1 with additional part-of-speech tag-
ging. We use this version to adapt the part-of-speech
tagger to the biomedical domain as mentioned in
Section 3.3.2 Downloaded from http://www-tsujii.is.s.u-tokyo.ac.jp/GENIA/.
3 In previous work on GENIA V1.1, there are 23 name classes due
to inconsistent annotations of class ORGANISM. According to
GENIA ontology, ORGANISM is not a name class in V3.02. We do
not diﬀerentiate the subclasses of PROTEIN, DNA, and RNA.
418 J. Zhang et al. / Journal of Biomedical Informatics 37 (2004) 411–422GENIA Version 3.02 (V3.02)—It consists of 2000
MEDLINE abstracts, which is a superset of the GENIA
Version 1.1. We use this version to get the latest result
and ﬁnd out the eﬀect of training data size.
5.2. Experimental results
The performance of our system is evaluated using
‘‘precision/recall/F-measure,’’ in which ‘‘precision’’ is
calculated as the ratio of the number of correctly found
named entities to the total number of named entities
found by our model; ‘‘recall’’ is calculated as the ratio
of the number of correctly found named entities to the
number of true named entities; and ‘‘F-measure’’ is de-
ﬁned by formula (5).
F -measure ¼ 2 precision recall
precisionþ recall : ð5Þ
We conduct experiments for the biomedical NER on
the both GENIA V1.1 and V3.02. For the GENIA V1.1,
we split the corpus into a training set of 590 abstracts
and a test set of 80 abstracts. We keep the same train-
ing/test ratio as [4] in order to make comparisons. For
the GENIA V3.02, the 2000 abstracts are split to a train-
ing set of 1920 abstracts and a test set of 80 abstracts.
The test set is the same as the test set for the GENIA
V1.1. In summary, the setting for the biomedical NER
is shown in Table 7.
On the GENIA V1.1, our system (62.5 F-mea-
sure) outperforms [4] (54.4 F-measure) by 8.1 F-
measure. It probably beneﬁts from the rich features
and the eﬀective methods proposed. Furthermore, as
expected, the performance on the GENIA V3.02
(66.5 F-measure) is better than that on the V1.1
(62.5 F-measure).
Besides the overall performance, we also evaluate
performances of all the entity classes, which are shown
in Fig. 4. From Fig. 4, we can ﬁnd that the performances
vary a lot among the diﬀerent entity classes. It is proba-
bly due to two reasons. First, diﬀerent entity classes
have diﬀerent diﬃculties for the named entity recogni-
tion. For example, BODY-PART is one of the easiest
entity classes since the number of instances for body
part is limited. Second, the numbers of the training
and test instances are not evenly distributed among all
the entity classes. Some minor classes, such as NUCLE-
OTIDE, ATOM, INORGANIC, CARBOHYDRATETable 7
Overall performance of biomedical named entity recognition on
GENIA corpus V3.02 and V1.1, comparing to Kazamas [4] on
GENIA corpus V1.1.
Precision Recall F-measure
Our model on V3.02 67.7 65.3 66.5
Our model on V1.1 63.8 61.3 62.5
Kazamas [4] on V1.1 56.2 52.8 54.4and, etc., lack enough data to achieve acceptable
performances.
Furthermore, in order to evaluate the contributions
of the diﬀerent features, we evaluate our system using
the diﬀerent combinations of the features. The results
are shown in Table 8.
From Table 8, several ﬁndings are concluded:
(1) Based on the orthographic feature (Fo), our system
achieves a basic level performance of 28.7 F-mea-
sure. In MUC-7 task, performance can reach 77.6
F-measure by using the orthographic feature only
[1]. It suggests that in the biomedical domain the
orthographic feature is not so informative.
(2) The head noun trigger feature (Fhnt) is proven very
useful. It greatly improves the F-measure (+21.1
based on Fo; +18.3 based on Fo + Fm; +9.4 based
on Fo + Fpos; +7.3 based on Fo + Fm + Fpos).
(3) The part-of-speech feature (Fpos) also makes signif-
icant improvement on F-measure (+23.6 based
on Fo; +23.1 based on Fo + Fm; +11.9 based
on Fo + Fhnt; +12.1 based on Fo + Fm + Fhnt). It
greatly beneﬁts from the eﬀective adaptation
of the part-of-speech tagger to the biomedical
domain.
(4) The morphological feature (Fm) leads to the positive
eﬀect by +2.7 F-measure improvement based on Fo
and +2.2 F-measure improvement based on Fo +
Fpos. However, it cannot make improvement based
on Fo + Fhnt and can only slightly improve the recall
by +0.2 based on Fo + Fpos + Fhnt. The probable rea-
son is that Fm and Fhnt provide some overlapping
information. The information captured by Fm may
also be captured by Fhnt. Moreover, the information
captured by Fhnt is more accurate than that captured
by Fm. The contribution made by Fm may come
from where there is no indication of Fhnt.
(5) Out of our expectation, the special verb trigger fea-
ture (Fsvt) decreases both precision and recall and
degrades the F-measure by 1.8 based on
Fo + Fm + Fpos + Fhnt.
To evaluate our proposed methods for abbreviation
and cascaded named entity recognition, we make further
experiments based on the four features which lead to the
best performance as shown above. The results are sum-
marized in Table 9.
First, we evaluate the contribution of the abbreviation
recognition method. The result shows that the method
leads to an improvement on F-measure by 1.2 based on
the best combination of features Fo + Fm + Fpos + Fhnt
(4F). The reason why the improvement is not so signiﬁ-
cant is that our abbreviation recognition method mainly
relies on the recognition of its full form.Once the full form
is wrongly recognized, all abbreviations can be wrong
altogether. However, the principle of the method is rea-
Fig. 4. Performance of each named entity class.
Table 8
Experimental results for biomedical named entity recognition by using
diﬀerent combinations of features
Fo Fm Fpos Fhnt Fsvt Precision Recall F-measure
X 41.8 21.8 28.7
X X 44.4 24.3 31.4
X X 55.7 49.4 52.3
X X 55.9 44.9 49.8
X X X 58.0 51.3 54.5
X X X 55.8 44.8 49.7
X X X 61.9 61.5 61.7
X X X X 61.9 61.7 61.8
X X X X X 60.6 59.3 60.0
Table 9
Eﬀectiveness of abbreviation recognition method and two cascaded
named entity recognition methods
V3.02 Precision Recall F-measure
Fo + Fm + Fpos + Fhnt (4F) 61.9 61.7 61.8
4F + abbreviation recognition 63.4 62.7 63.0
4F + abbr. + post-processing
rule-based appr.
67.7 65.3 66.5
4F + abbr. + HMM-based appr. 65.5 63.0 64.2
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nition method provides an eﬀective and reasonable solu-
tion when domain-speciﬁc abbreviation dictionaries are
not available.Furthermore, we evaluate the two approaches for
cascaded named entity recognition proposed in section
4.3. Using post-processing rule-based cascaded recogni-
tion approach, we get a signiﬁcant improvement by 3.5
F-measure. Another approach, the HMM-based cas-
caded recognition approach, also leads to a positive
eﬀect of +1.2 F-measure. We can ﬁnd that the post-pro-
cessing rule-based approach outperforms the HMM-
based approach. It is probably because we do not have
enough training data with the cascaded annotation for
the HMM-based approach to get a reliable perfor-
mance. However, the HMM-based approach is more
general and can be enhanced when we have more train-
ing instances with the cascaded annotation.6. Related work
This section presents a review of the recent literatures
on the biomedical named entity recognition. We group
them into rule-based and machine learning-based
approaches.
6.1. Rule-based approaches
As for rule-based approaches, the representative
research eﬀorts include [10,12,9].
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ER (Protein Proper-noun phrase Extracting Rules),
which attempts to identify protein names from biomed-
ical documents based on surface clues of character
strings, such as the presence of upper cases and special
characters. They summarize the nomenclature of the
protein names into three categories based on the surface
characteristics of word. Their system is evaluated on 30
annotated MEDLINE abstracts on SH3 domain and
achieves the precision of 91.90% and the recall of
93.32%.
Proux et al. [12] detects gene names in biomedical
documents based on lexical and morphological infor-
mation. They make use of a ﬁnite state-based tagger
to conduct the lexical and morphological analysis of
each word in the ﬁrst level. The tagger tokenizes the
sentences, conducts a lexical lookup to process the
morphological analysis and performs the part-of-speech
tagging. Each word in the sentence is given various tags
and a special ﬂag. The tags include noun, proper noun
and abbreviation, etc. The special ﬂag indicates
whether the word matches a known word or is
‘‘guessed.’’ Based on the tags and the special ﬂag, they
build a series of rules including recovery rules, algorith-
mic rules, and contextual rules. Their system achieves
the precision of 91.4% and the recall of 94.4% on a
small corpus (1200 sentences) from FlyBase. However,
they ﬁnd that when they apply the system to a larger
corpus (25,000 MEDLINE abstracts) and evaluate the
performance by sampling, the precision is reduced to
around 70%.
Gaizauskas et al. [9] derives their system from a
developed Information Extraction system in the
MUC. Their system consists of ﬁve processing stages:
text processing, morphological analysis, term lookup,
terminology parsing, and term matching. The main
information resources include case-insensitive terminol-
ogy lexicons (the component term of various categories)
such as the resources from the public databases
(SWISS-PROT, CATH, and SCOP), morphological
cues (standard biochemical suﬃxes) and hand-con-
structed grammar rules for each terminology class.
Their system is applied in two projects: extraction of
information about enzymes and metabolic pathways
(EMPathIE) and extraction of information about pro-
tein structure (PASTA). The EMPathIE system is de-
signed for 10 named entity classes, such as compound,
element, enzyme, etc., and achieves the precision of
86% and the recall of 68% on 6 full journal articles.
The PASTA system is designed for 13 named entity
classes, such as protein, species, residue, etc., and
achieves the precision of 94% and the recall of 88% on
52 MEDLINE abstracts.
Tanabe and Wilbur [13] proposes a method using a
combination of statistical and knowledge-based strate-
gies. They use a transformation-based part-of-speechtagger to generate rules automatically, as well as manu-
ally generated rules concerning morphological and part-
of-speech information, low frequency trigrams, suﬃxes
and indicator terms. They conduct experiments to detect
protein/gene names (class GENE). The test set consists
of 56469 MEDLINE abstracts. They randomly check
100 sentences out of every 50K sentences in the test
set. Their method achieves the precision of 85.7% and
the recall of 66.7%.
Although these rule-based systems seem quite prom-
ising, it is costly to adapt them to new entity classes in
the biomedical domain. Once a new entity class is de-
ﬁned, a set of new rules has to be prepared manually.
Consequently, the more classes are, the more diﬃcult
to construct consistent rules. Moreover, up to now,
the evaluations of these systems are only based on small
corpora. Proux et al. [12] reports their system fails in a
larger corpus. Rule-based systems seem not to be robust
and ﬂexible.
6.2. Machine-learning approaches
Currently, the machine learning-based approaches be-
come more and more popular in the biomedical named
entity recognition. The typical works include [6,8,5,4].
Nobata et al. [6] tries two classiﬁcation methods and
three identiﬁcation methods for the biomedical named
entity recognition. The ﬁrst classiﬁcation method in-
duces a Naı¨ve Bayes classiﬁer using conditional proba-
bilities between word and class from the distribution
of words in pre-classiﬁed domain-speciﬁc word lists.
The second classiﬁcation method uses a decision tree
approach which incorporates the feature sets of part-
of-speech information, character type information and
domain speciﬁc word lists. The three identiﬁcation
methods include shallow parsing, decision trees and sta-
tistical identiﬁcation. The system recognizes 10 entity
classes, such as protein, DNA, RNA, cell line, cell type,
etc. They conduct a series of experiments by combina-
tion of each classiﬁcation and identiﬁcation method.
The experiments show that by using both decision tree
methods for classiﬁcation and identiﬁcation, they
achieve the best F-measure of 56.98–66.24 on 100 man-
ually annotated MEDLINE abstracts by 5-fold cross
validation. The corpus is a preliminary version of the
GENIA corpus.
Collier et al. [8] applies linear interpolating HMM for
gene name recognition. They train the HMM entirely
based on surface word and character information. The
classes and the corpus are the same as those in [6].
The system achieves the F-measure of 72.8.
Takeuchi and Collier [5] uses SVM. The model incor-
porates surface word, orthographic feature and the class
assignments of context words. The window size of con-
text is 3 to +3. In their experiment, they ﬁnd that part-
of-speech features degrade the performance in their
J. Zhang et al. / Journal of Biomedical Informatics 37 (2004) 411–422 421model. The evaluation is also conducted on the same
corpus as used in [6] and the F-measure is 71.78.
Kazama et al. [4] also develops a system using SVM.
To our knowledge, it is the earliest published work on
the GENIA V1.1, which contains 670 MEDLINE ab-
stracts and 24 named entity classes. Compared with
[6], they make use of richer features, such as word fea-
ture, part-of-speech feature, preﬁx feature, suﬃx feature,
previous class feature, word cache feature and HMM
state feature. They use a BIO (beginning/in/out of entity)
representation to classify a word. Since SVM is a binary
classiﬁer, they use the pair-wise strategy to construct a
multi-class classiﬁer. In addition, they use a class split-
ting technique to balance the class distribution. Since
there are too many samples of the class ‘‘O,’’ they split
class ‘‘O’’ into several subclasses by combining the class
‘‘O’’ and the part-of-speech tags, such as ‘‘O-NN,’’ ‘‘O-
JJ’’ and etc. Their system achieves F-measure of 54.4 on
the GENIA V1.1.
Certainly, it is diﬃcult to compare the various models
because of the diﬀerent experimental settings. Since
[6,8,5] use the same class and corpus, we make a rough
comparison among them. The results show that the
HMM and the SVM outperform the decision tree and
the performance of the HMM and the SVM are almost
equivalent. The results also show that how to capture
the useful information for domain-speciﬁc named enti-
ties and how to integrate them eﬀectively in the model
is crucial. In this respect, [8] only use the surface word
and the character information, which may not be ade-
quate for coping with the complicated biomedical
named entities.7. Conclusion
In the paper, we introduce the enhancement of a
HMM-based biomedical named entity recognizer by
studying various special phenomena, such as abbrevi-
ations, cascaded named entities and etc. We integrate
rich features, such as the orthographic, morphological,
part of speech and semantic information. In addition,
we present an abbreviation recognition method to rec-
ognize the abbreviation according to its full form. We
also present a post-processing rule-based cascaded rec-
ognition approach and an HMM-based cascaded rec-
ognition approach to extend the biomedical named
entity recognition. To our best knowledge, our work
is the ﬁrst research work to cope with the cascaded
phenomena in the biomedical domain. Based on the
rich features and the methods, our system is success-
fully adapted to the biomedical domain and achieves
signiﬁcantly better performance than the previous best
published system. The limitation of our method is that
some complicated constructions, such as ‘‘and/or,’’
may not be eﬀectively handled. In the near future, fur-ther explorations can be made on the complicated
constructions in the biomedical documents. One possi-
ble way is to develop some eﬀective patterns for the
conjunction and disjunction construction. In addition,
existing public resources and databases can be inte-
grated in our system.References
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